# Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients

> **NCT04500522** · PHASE4 · COMPLETED · sponsor: **Aswan University Hospital** · enrollment: 150 (actual)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** INH
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04500522
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-09-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500522, "Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04500522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*